anderson cancer center

(University of Texas M. D. Anderson Cancer Center) A new immunotherapy for companion dogs with advanced-stage non-Hodgkin lymphoma has been shown to improve survival while maintaining quality of life, according to a study published in the journal Scientific Reports.

(University of Texas M. D. Anderson Cancer Center) When SUMO grips STAT5, a protein that activates genes, it blocks the healthy embryonic development of immune B cells and T cells unless its nemesis breaks the hold, a research team led by scientists at the University of Texas MD Anderson Cancer Center reports today in Molecular Cell.

(University of Texas M. D. Anderson Cancer Center) A large-scale analysis of patients whose myelodysplastic syndrome is related to earlier cancer treatment overturns the notion that all of them have a poor prognosis, researchers from the University of Texas MD Anderson Cancer Center report at the 53rd Annual Meeting of the American Society of Hematology.

(University of Texas M. D. Anderson Cancer Center) A new, targeted approach to treating chronic lymphocytic leukemia has produced durable remissions in a Phase I/II clinical trial for patients with relapsed or resistant disease, investigators report at the 53rd Annual Meeting of the American Society of Hematology.

(University of Texas M. D. Anderson Cancer Center) Academic and government leaders announced today the establishment of a major new research institute at the University of Texas MD Anderson Cancer Center that will blend the best attributes of academic and industrial research to identify and validate new cancer targets, convert such scientific knowledge into new cancer drugs, and advance these novel agents into innovative clinical trials.

(University of Texas M. D. Anderson Cancer Center) The embryonic enzyme pyruvate kinase M2 (PKM2) has a well-established role in metabolism and is highly expressed in human cancers.

Now, a team led by researchers at the University of Texas MD Anderson Cancer Center reports in advance online publication of the journal Nature that PKM2 has important non-metabolic functions in cancer formation.

(University of Texas M. D. Anderson Cancer Center) Women with a deleterious gene mutation are diagnosed with breast cancer almost eight years earlier than relatives of the previous generation who also had the disease and/or ovarian cancer, according to new research from the University of Texas MD Anderson Cancer Center.

(University of Texas M. D. Anderson Cancer Center) Whether chemotherapy is given before or after breast-conserving therapy (BCT) does not have an impact on long-term local-regional outcomes, suggesting treatment success is due more to biologic factors than chemotherapy timing, according to a study by researchers at the University of Texas MD Anderson Cancer Center.

(University of Texas M. D. Anderson Cancer Center) A protein known as WWP2 appears to play a key role in tumor survival, a research team headed by a scientist at The University of Texas MD Anderson Cancer Center reports in an advance online publication of Nature Cell Biology.

(University of Texas M. D. Anderson Cancer Center) Low health literacy is a significant barrier to quality care, especially among elderly patients, but increased use of simple and effective health literacy assessment tests by nurses and clinicians can help improve communication and health outcomes.